BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2117328)

  • 21. Pentazocine-induced agranulocytosis.
    Haibach H; Yesus YW; Doggett JJ
    Can Med Assoc J; 1984 May; 130(9):1165-6. PubMed ID: 6713337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors of hematologic recovery in nonchemotherapy drug-induced agranulocytosis.
    Maloisel F; Andrès E; Kaltenbach G; Noel E; Koumarianou A
    Haematologica; 2003 Apr; 88(4):470-1. PubMed ID: 12681976
    [No Abstract]   [Full Text] [Related]  

  • 23. [Amiodarone and verapamil/quinidine in treatment of patients with chronic atrial fibrillation].
    Zehender M; Meinertz T; Just H
    Z Kardiol; 1994; 83 Suppl 5():101-8. PubMed ID: 7846938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agranulocytosis associated with procainamide therapy--report of a case.
    Prince RA; Brown BT; Jacknowitz AI
    Am J Hosp Pharm; 1977 Dec; 34(12):1362-5. PubMed ID: 596390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment and prevention of paroxysmal atrial fibrillation and flutter with quinidine retard].
    Petrova V; Penkov N; Kaponov Kh; Ivanov D
    Vutr Boles; 1985; 24(3):83-8. PubMed ID: 3895746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined administration of quinidine and propafenone for atrial fibrillation: the CAQ-PAF study.
    O'Hara GE; Philippon F; Gilbert M; Champagne J; Michaud V; Charbonneau L; Pruneau G; Hamelin BA; Geelen P; Turgeon J
    J Clin Pharmacol; 2012 Feb; 52(2):171-9. PubMed ID: 21508180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Factors effecting quinidine concentration in blood and restoration of sinus rhythm in cardiac fibrillation].
    Ivanenko NA
    Vrach Delo; 1969 Aug; 8():5-8. PubMed ID: 5382490
    [No Abstract]   [Full Text] [Related]  

  • 28. Methimazole-induced agranulocytosis preceded by transient granulocytopenia. A case report.
    Schut NH; Wiersinga WM; Van Oers MH
    Neth J Med; 1993 Aug; 43(1-2):71-3. PubMed ID: 8232698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spironolactone-induced agranulocytosis: a case report.
    Hsiao SH; Lin YJ; Hsu MY; Wu TJ
    Kaohsiung J Med Sci; 2003 Nov; 19(11):574-8. PubMed ID: 14658487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous amiodarone bolus versus oral quinidine for atrial flutter and fibrillation after cardiac operations.
    McAlister HF; Luke RA; Whitlock RM; Smith WM
    J Thorac Cardiovasc Surg; 1990 May; 99(5):911-8. PubMed ID: 2184287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monocyte and Basophil Counts as Predictors of Neutrophil Count Recovery in Patients with Thiamazole-Induced Agranulocytosis.
    Onose H; Uchida T; Sato J; Ishii S; Yamada E; Yamada T; Watada H
    Exp Clin Endocrinol Diabetes; 2017 Jan; 125(1):49-52. PubMed ID: 27219883
    [No Abstract]   [Full Text] [Related]  

  • 32. Agranulocytosis in a patient with thalassaemia major during treatment with the oral iron chelator, 1,2-dimethyl-3-hydroxypyrid-4-one.
    al-Refaie FN; Veys PA; Wilkes S; Wonke B; Hoffbrand AV
    Acta Haematol; 1993; 89(2):86-90. PubMed ID: 8503250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged quinidine half-life with associated toxicity in a patient with hepatic failure.
    Stanek EJ; Simko RJ; DeNofrio D; Pavri BB
    Pharmacotherapy; 1997; 17(3):622-5. PubMed ID: 9165569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A comparison between propafenone and hydroquinidine perorally in the treatment of recent-onset atrial fibrillation].
    Satullo G; Arrigo F; Cavallaro L; Coglitore A; Fazio F; Saporito F; Sorrenti S; Oreto G
    Minerva Cardioangiol; 1996 Mar; 44(3):141-4. PubMed ID: 8767614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The use of digitalis glycosides in atrial fibrillation].
    Knez A; Haberl R; Steinbeck G
    Z Kardiol; 1994; 83 Suppl 5():71-3. PubMed ID: 7846948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Problems of evaluating rare adverse drug reactions using as an example agranulocytosis induced by anti-arrhythmia agents].
    Knipping W
    Med Klin; 1980 Feb; 75(3):108-15. PubMed ID: 7374607
    [No Abstract]   [Full Text] [Related]  

  • 38. [Quinidine treatment of paroxysms of atrial fibrillation and flutter].
    Kalvelis AD; Braun VB; Dumesh SZ; Orlova VP; Gurvich TR
    Klin Med (Mosk); 1984 Mar; 62(3):103-7. PubMed ID: 6716916
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of atrial fibrillation using intravenous infusion of quinidine].
    Vidaurri A; Pastelín G; Méndez R; Cárdenas M
    Arch Inst Cardiol Mex; 1983; 53(1):5-11. PubMed ID: 6223605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quinidine-induced thrombocytopenia with pulmonary hemorrhage.
    Alperin JB; deGroot WJ; Cimo PL
    Arch Intern Med; 1980 Feb; 140(2):266-7. PubMed ID: 7352824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.